DrugsControl Media Services
DrugsControl.org

News Detail

Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab (26-12-2024)

Mumbai, 26 Dec 2024: Mankind Pharma and Innovent Biologics have announced a partnership to exclusively license and commercialise sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatm......
View Details

Source : Express Pharma
Mankind Pharma Innovent Sintilimab Sintilimab in India immunotherapy

Related News